Real-time enrollment status for this cytomegalovirus prophylaxis clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:08 PM UTC
| NCT Number | NCT07199465 |
| Recruiting Status | Recruiting |
| Condition | Cytomegalovirus Prophylaxis |
| Phase | PHASE1 |
| Target Enrollment | 40 participants |
| Active Locations | 21 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | October 13, 2026 (1 week ago) |
As of October 21, 2026: Clinical trial NCT07199465 is currently recruiting participants. This phase1 study for cytomegalovirus prophylaxis is actively seeking new participants at 21 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07199465 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07199465 was last updated 1 week ago (October 13, 2026). HelloStudys verifies this status automatically.